MarketInOut Stock Screener Log In | Sign Up
 

Cytek Biosciences Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Cytek Biosciences Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization705.81 mln
Float119 mln
Earnings Date11/04/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.61
Highly reliable

Relative Strength

84 / 100
Strongly outperforming

Debt / Equity

0.11
Very low leverage

Pre-Tax Margin

-20%
Loss-making

ROE

-23.06
Deeply negative

Business Description

Founded in 1992 and headquartered in Fremont, California, Cytek Biosciences develops and sells instruments, software, and reagents that help scientists study cells in detail for biomedical research and clinical use. The company's product lineup includes a range of flow cytometers, imaging systems, and cell analyzers sold under the Cytek, Amnis, and Guava brands, along with supporting software and consumables. Cytek serves pharmaceutical companies, academic institutions, and contract research organizations, reaching customers through its own sales teams in North America, Europe, China, and the Asia-Pacific region, as well as through third-party distributors elsewhere in the world.

Key Fundamentals

EPS-0.62
ROE-23.06
RPS1.61
ROIC-23.54
ROA-17.17
Interest Cover-25.34
EBITDA, mln-27.88
EV / EBITDA-19.57
EV / EBIT-13.71
Revenue, mln207
EV / Revenue2.64

Quote Details

Last 5.59
Change 0.16 (2.95%)
Open 5.38
Volume 704,855
Turnover 3,940,140
Average Volume 1,339,513

Financial Ratios

Pre-Tax Profit Margin-20
Leverage Ratio1.39
Current Ratio4.48
Price / Book2.40
Price / Tangible Book2.67
Debt / Equity0.11
Price / Sales3.69

Financial Strength

Altman Z-Score4.14
Piotroski F-Score 3 / 9
Beneish M-Score-3.61
Price to Intrinsic Value3.03
Short Ratio4.00
Short % of Float5.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.48% 91 / 100   
1 Month -2.44% 49 / 100   
2 Months 22.05% 93 / 100   
6 Months 27.05% 91 / 100   
1 Year 36.01% 88 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog